Skip to content
The Touch and GoThe Touch and Go
FAA Opens Antidepressant Certification to Any AME and Cuts Post-Medication Wait to 60 Days

AI-generated illustration

Regulatory

FAA Opens Antidepressant Certification to Any AME and Cuts Post-Medication Wait to 60 Days

Pilots on FAA-accepted antidepressants no longer need a HIMS-trained examiner, and the wait to reapply after stopping medication drops from 90 days to 60, changes NBAA welcomed on Nov. 20.

By The Touch & Go EditorialPublished Nov 21, 1:45 AM2 min read

The gist

Pilots on accepted antidepressants can now use any AME, and the post-medication reapplication wait falls from 90 to 60 days.

Continuing coverage

All Faa →

The Federal Aviation Administration has revised its aeromedical mental wellness procedures so that pilots taking an FAA-accepted antidepressant can obtain initial and follow-up medical certification from any aviation medical examiner, rather than only from a human intervention motivation study (HIMS) AME. The National Business Aviation Association welcomed the changes on Nov. 20, 2026.

The package goes beyond the examiner rule. The FAA shortened the waiting period before a pilot may reapply for certification after discontinuing antidepressant medication from 90 days to 60. It also folded the earlier selective serotonin reuptake inhibitor decision pathways into diagnosis-based disposition tables, consolidating existing requirements and documentation into one structure. The agency added resources intended to help pilots work through the medical certification process.

Dosage changes are also handled differently now. Under certain circumstances, a pilot changing an antidepressant dose may temporarily ground themselves and then return to flying without additional notification to the FAA, subject to the terms of their authorization. Previously, the narrower framework added steps to that kind of adjustment.

Laila Stein, NBAA flight operations manager and the association's aeromedical lead, said dropping the HIMS requirement expands the number of examiners able to work with aviators on antidepressants nearly tenfold. She said that gives pilots more choice and could reduce costs, travel and delays. Stein also cautioned that a pilot's new AME may not have the same experience with mental wellness cases as a HIMS-trained examiner, so the handling of a case may vary from one office to another.

For business aviation crews, the obstacle to treatment has often been the certification process surrounding a medication rather than the medication itself. Limiting antidepressant cases to a small pool of specialist examiners meant longer trips, higher fees and scheduling conflicts, each of which could push a pilot to put off care or not disclose a condition. Moving the work into ordinary AME offices removes much of that travel and cost.

Mark Larsen, CAM, NBAA director of safety and flight operations, said pilots can talk with their AME before the formal medical exam, including about how to fill out the MedXpress application. He said having all required information on hand at the exam can strongly affect how quickly the AME or the FAA processes an application. That matters most in cases where the AME cannot issue the certificate directly and the file must go to the FAA.

Whether the larger examiner pool actually shortens processing times will depend partly on that preparation. Incomplete MedXpress submissions or unfamiliar examiners could shift delays to the FAA review stage rather than eliminate them.

NBAA said it continues to press for aeromedical policies that encourage pilots to seek early treatment for mental health and other medical concerns while protecting aviation safety.

Originally reported by Avi-Go

Share

The Daily Touch & Go

The day's best aviation news in your inbox. Free, no spam.